article thumbnail

A Pharma Playbook for Success in Southeast Asia

BCG

To capture the immense opportunities in emerging markets, pharmaceutical companies require highly targeted strategies. And what works in developed markets won’t necessarily work in emerging economies. By 2020, emerging markets will account for more than 30% of pharmaceutical sales growth worldwide.

article thumbnail

How Pharma Companies Can Keep Winning in China’s Changing Market

BCG

Focus Tuesday, November 22, 2016 Big shifts are underway in China’s pharmaceutical market. They will shape the marketplace for more than 90% of drug sales for the next decade for multi-national corporations and domestic players.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sales Bonuses Are Supposed to Motivate, So Don’t Waste Them on Easy Targets

Harvard Business

The belief is that at-risk pay motivates salespeople to work hard and direct effort towards sales activities that encourage achievement of sales goals. sales forces, but the mix varies across industries and sales roles. Within an industry or company, pay mix often varies across sales roles.

Sales 28
article thumbnail

Fixing Pharma’s Incentives Problem in the Wake of the U.S. Opioid Crisis

Harvard Business

Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. Meanwhile, the amount of prescription opioids sold by pharmaceutical companies has quadrupled, despite no proliferation in the amount of reported pain.

article thumbnail

Simon-Kucher & Partners Interviews & Culture

Management Consulted

Though the firm’s background is exclusively in pricing, in more recent years it has been breaking into other practice areas such as strategy, marketing, and sales. In 1996, Simon-Kucher opened an office in Boston and began to put more of a focus on its other three practice areas: strategy, marketing, and sales. Practice Areas.

article thumbnail

The DNA of a New Species of Leaders

Rick Conlow

” Since Price implemented his plan sales growth and profits doubled. In contrast, is Martin Shkreli a pharmaceutical executive. In addition, go here for our RealTime Learning & Training leadership and personal development website. Now I am look for something meaningful and fun.” His antics caused a firestorm.

eBook 52
article thumbnail

Research: Innovation Suffers When Drug Companies Merge

Harvard Business

Regulators try to model how prices, sales, and even the combining parties’ research and development efforts will change after a merger. This is especially true in pharmaceutical markets where new and affordable drugs can improve and even save the lives of many people. Sometimes, approval is granted on certain conditions.